Fulcrum Therapeutics, Inc. (FULC) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,980
Total Return
-60.20%
CAGR
-16.83%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +6.49% |
| Median | +1.76% |
| Best | +306.29% |
| Worst | -75.56% |
| % of Windows Positive | 52.4% |
1-Year (252 Trading Days)
| Average | +17.71% |
| Median | -21.52% |
| Best | +292.64% |
| Worst | -90.03% |
| % of Windows Positive | 35.8% |
3-Year (756 Trading Days)
| Average | -5.07% |
| Median | -15.01% |
| Best | +251.33% |
| Worst | -89.64% |
| % of Windows Positive | 39.1% |
Risk Metrics
| Maximum Drawdown | -92.70% |
| Average Drawdown | -70.23% |
| Drawdown Duration | 1179 Trading Days (Unrecovered) |
| Sortino Ratio | 0.61 |
| Calmar Ratio | -0.18 |
| CVaR (5%) | -12.89% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -71.53% (-94.92% ann.) | $7152.96 | $0.00 | $0.00 | $0.00 |
| 2025 | +140.64% | +$14063.85 | $0.00 | $0.00 | $0.00 |
| 2024 | -30.37% | $3037.04 | $0.00 | $0.00 | $0.00 |
| 2023 | -7.28% | $728.02 | $0.00 | $0.00 | $0.00 |
| 2022 | -58.85% | $5884.68 | $0.00 | $0.00 | $0.00 |
| 2021 | +51.07% | +$5106.75 | $0.00 | $0.00 | $0.00 |
| 2020 | -29.63% | $2962.75 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +23.26% (+58.43% ann.) | +$2325.93 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 18, 2019 – February 19, 2020 | +27.33% | +50.47% | +$2733.33 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -49.95% | -99.96% | $4994.72 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +22.79% | +39.14% | +$2278.87 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +32.44% | +30.54% | +$3243.99 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -52.07% | -54.20% | $5206.89 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -51.99% | -32.69% | $5199.45 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -6.40% | -3.80% | $639.52 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.